OrthoPediatrics Corp.
OrthoPediatrics Corp. Score & Ratio Trend
| Date | Score | P/E | P/B | D/E | Price |
|---|---|---|---|---|---|
| Oct 2026 | 19,917 | -13.1 | 1.67 | 0.32 | 2,088.48 |
| Oct 2026 | 19,845 | -13.2 | 1.69 | 0.32 | 2,112.58 |
| Oct 2026 | 19,773 | -13.3 | 1.72 | 0.32 | 2,143.27 |
| Oct 2026 | 19,913 | -13.1 | 1.67 | 0.32 | 2,078.99 |
| Oct 2026 | 19,895 | -13.1 | 1.67 | 0.32 | 2,088.81 |
| Oct 2026 | 19,563 | -14.0 | 1.79 | 0.32 | 2,228.19 |
| Oct 2026 | 19,487 | -14.2 | 1.81 | 0.32 | 2,254.84 |
| Oct 2026 | 19,290 | -14.7 | 1.88 | 0.32 | 2,332.40 |
OrthoPediatrics Corp. Quarterly Results
| Line Item | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 |
|---|---|---|---|---|
| Revenue | 70,508,000.0 | 59,362,000.0 | 61,605,000.0 | 61,250,000.0 |
| Net Profit | -7,163,000.0 | -10,687,000.0 | -10,103,000.0 | -11,773,000.0 |
| EPS | -0.3 | -0.5 | -0.4 | -0.5 |
OrthoPediatrics Corp. Revenue & Profit: Last 5 Years
| Line Item | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|
| Revenue | 236,348,000.0 | 204,727,000.0 | 148,732,000.0 | 122,289,000.0 | — |
| Net Profit | -39,648,000.0 | -37,822,000.0 | -20,974,000.0 | 1,258,000.0 | — |
| EPS | -1.7 | -1.6 | -0.9 | 0.1 | — |
OrthoPediatrics Corp. Balance Sheet
| Line Item | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|
| Total Assets | 508,630,000.0 | 473,209,000.0 | 438,745,000.0 | 427,727,000.0 | — |
| Total Liabilities | 162,034,000.0 | 118,643,000.0 | 61,720,000.0 | 49,079,000.0 | — |
| Total Equity | 346,596,000.0 | 354,566,000.0 | 377,025,000.0 | 378,648,000.0 | — |
Owes vs Owns
OrthoPediatrics Corp. owed $0.33 for every $1 it owned in Jun 2026, up from $0.11 in Dec 2022.
| Period | Jun 2026 | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 |
|---|---|---|---|---|---|
| Owes vs Owns | 0.33× | 0.32× | 0.25× | 0.14× | 0.11× |
Everything the company owes ÷ everything it owns. Below 1× it owns more than it owes; above 1× it owes more than it owns.
OrthoPediatrics Corp. Assets & Liabilities Breakdown (USD millions)
What it owns — Dec 2025
How it's funded — Dec 2025
| Line Item | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 |
|---|---|---|---|---|
| Assets | ||||
| Cash & short-term investments | 60.9 | 68.8 | 80.3 | 118.3 |
| Receivables | 53.8 | 42.4 | 34.6 | 24.8 |
| Inventory | 133.8 | 117.0 | 105.9 | 78.2 |
| Fixed assets (tangible) | 49.6 | 50.6 | 41.0 | 34.3 |
| Intangible assets | 187.0 | 175.0 | 168.3 | 166.7 |
| Long-term investments | 0.0 | 0.0 | 0.0 | 0.0 |
| Other assets | 23.6 | 19.4 | 8.7 | 5.4 |
| Liabilities & equity | ||||
| Short-term debt | 0.2 | 0.2 | 0.2 | 0.1 |
| Long-term debt | 99.8 | 73.0 | 9.9 | 0.8 |
| Payables | 18.8 | 8.9 | 12.6 | 11.2 |
| Other liabilities | 43.3 | 36.6 | 39.0 | 37.0 |
| Shareholders' equity | 346.6 | 354.6 | 377.0 | 378.6 |
| Net tangible assets | 159.6 | 179.5 | 208.8 | 211.9 |
OrthoPediatrics Corp. Cash Flow
| Line Item | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|
| Operating Activities | -4,851,000.0 | -27,048,000.0 | -27,046,000.0 | -21,766,000.0 | — |
| Investing Activities | -43,629,000.0 | -13,162,000.0 | 41,677,000.0 | -113,371,000.0 | — |
| Financing Activities | 23,975,000.0 | 53,135,000.0 | 7,301,000.0 | 135,974,000.0 | — |